|
REPL Replimune Group Inc 1737953 |
| Balance Sheet |
|
Current Assets
|
547,577,000 |
|
Assets
|
603,628,000 |
|
Current Liabilities
|
47,890,000 |
|
Liabilities
|
121,254,000 |
|
Equity
|
482,374,000 |
|
Shares Out
|
68,321,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-138,519,000 |
|
Investing Cash Flow
|
-16,096,000 |
| Market Analysis |
Market Cap
|
753,584,913 |
|
Price
|
11.50 |
|
BVPS
|
7.06 |
|
PB
|
1.59 |
|
EPS
|
-3.27 |
|
PS
|
0.73 |
|
FCF
|
-154,615,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view REPL documents filed with the SEC.
REPL Filings
Clear
